“This is a Japan-exclusive treatment method that has been approved by insurance.
The following are the indications for RFA based on the guidelines of the Japanese Breast Cancer Society.
■ Tumor size: 1.5 cm or smaller
・A single tumor confirmed by MRI or ultrasound
■ Tumor type: Typical primary ductal carcinoma
・Limited to specific types of breast cancer
■ No lymph node metastasis
・No axillary lymph node involvement or distant metastasis (Health tech for the digital age)
■ No skin invasion or changes
・No skin tightening or invasion (Kobe University School of Medicine)
■ No history of preoperative treatment
・No prior chemotherapy, hormone therapy, or radiation therapy (Kobe University School of Medicine)
■ Possibility of postoperative radiation therapy
・Ability to receive radiation therapy after RFA
■ Good health status for general anesthesia and surgery
・Able to withstand general anesthesia
RFA is a treatment method that burns the tumor without surgery, offering a new option for patients who prioritize aesthetics and quality of life.
However, there are strict criteria for eligibility, and the judgment of a specialist is required.
For more details, please consult with a breast surgery specialist or an accredited facility.
👉 The latest treatments are constantly evolving.
Choose based on reliable information.”
コメントを残す